| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
2.20
|
|
High: |
|
Low: |
|
Resistance:
|
1.88
2.20
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
1.48
1.23
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.60
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
1.66  |
Signal(12,26,9): |
0.05 |
|
MA(100): |
1.47 |
Stochastic Oscillator |
%K(14,3):
|
22.87 |
|
MA(250): |
2.13 |
%D(3): |
29.53 |
|
Average Volume(K) |
3-Month: |
7690
|
52-Week |
High:
|
5.75 |
|
10-Days: |
7063 |
Low: |
0.90 |
|
RSI |
RSI(14):
|
46.30 |
Change(%): |
-52.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.632 |
Return on Equity (ttm) |
-542.2 |
Shares Out. (M) |
7.42 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-183.3 |
Shares Float (M) |
7.11 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.51 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
18.35 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
768 |
|
Book Value (p.s.) |
0.250 |
EBITDA (p.s.) |
-1.222 |
P/E |
-0.96 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.24 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.57 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.11 |
P/CF |
-1.53 |
|
|
|
|
|
|
